| Financial Year |
March 31 2023 |
| Monetary Funds |
1,628,570,051.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
432,118,069.22 |
| Accounts Receivable |
446,497,620.86 |
| Advances to Suppliers |
28,237,860.13 |
| Other Receivables |
49,202,041.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
340,834,436.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,340,752.37 |
| Total Current Assets |
2,931,800,831.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
101,190,473.13 |
| Investment Properties |
31,189,337.84 |
| Fixed Assetes |
1,778,922,258.55 |
| Under-construction Projects |
1,574,149,655.51 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
106,628,155.59 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,807,936.27 |
| Deferred Income Tax Assets |
18,500,321.03 |
| Other Non-Current Assets |
519,099,910.00 |
| Sub-Total of Non-Current Assets |
4,134,703,929.87 |
| Total Assets |
7,066,504,761.54 |
| Short-Term Loans |
587,552,041.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
291,430,093.47 |
| Accounts Payable |
420,230,143.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
74,329.06 |
| Taxes Payable |
5,100,757.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
30,180,872.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
633,138,047.86 |
| Other Current Liabilities |
58,543,806.98 |
| Sub-Total of Current Liabilities |
2,078,888,487.54 |
| Long-term Loans |
1,529,511,549.80 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,743,772.98 |
| Other Non-Current Liabilities |
150,000,000.00 |
| Sub-Total of Non-Current Liabilities |
1,737,175,837.29 |
| Total Liabilities |
3,816,064,324.83 |
| Paid-In Capital(Or Share Stock) |
960,295,304.00 |
| Capital Surplus |
1,156,121,063.37 |
| Surplus Reserve |
134,785,353.11 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
997,110,920.05 |
| Minority Stockholder's Interest |
2,153,112.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,248,287,324.26 |
| Owner's Equity（Stockholder's Equity） |
3,250,440,436.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,066,504,761.54 |
